PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 9, 2026Cureus0 citationsOpen Access

Anti-Ku Antibodies in a Patient With a Polymyositis-Systemic Sclerosis Overlap Syndrome in Association With Autoimmune Hepatitis

MZMuhammad ZubairMWMaha WazirFUFarhan Ullah

Key Points

  • To present a rare case of a patient with polymyositis-systemic sclerosis overlap syndrome and autoimmune hepatitis characterized by anti-Ku antibodies.
  • Performed blood tests revealing positive antinuclear and anti-Ku antibodies, raised creatine kinase, and immunological testing.
  • Conducted liver biopsy to confirm autoimmune hepatitis alongside imaging studies indicating myositis and interstitial lung disease.
  • Managed the patient with corticosteroids and mycophenolate mofetil.
  • Patient was confirmed to have polymyositis-systemic sclerosis overlap syndrome with raised liver transaminases indicative of autoimmune hepatitis.
  • Only the second reported instance of autoimmune hepatitis in a patient with a positive anti-Ku antibody.
  • Management resulted in symptom stabilization with treatment.

Abstract

Overlap syndromes are well-described but rare clinical entities characterized by the co-presence of two or more connective tissue diseases. The combination of systemic sclerosis and polymyositis overlapping with autoimmune hepatitis (AIH) is particularly rare, as discussed in this case report. A 76-year-old woman with a recent history of pleuro-pericarditis presented with painful Raynaud’s phenomenon, lethargy, jaundice, myalgias, and weight loss. Blood tests revealed a positive antinuclear antibody and anti-Ku antibody and raised creatine kinase, together with evidence of myositis and interstitial lung disease on imaging, leading to a diagnosis of polymyositis-systemic sclerosis overlap syndrome. Raised liver transaminases, immunological tests, and liver biopsy were consistent with AIH. She was managed with corticosteroids and mycophenolate mofetil. This is only the second instance in which AIH has been reported in the context of a positive anti-Ku antibody. We discussed the complex and rare nature of this condition and the various aspects of its management.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zubair et al. (2026) studied this question.

synapsesocial.com/papers/69fed021b9154b0b8287720chttps://doi.org/10.7759/cureus.108420
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autoimmune Hepatitis and Systemic Sclerosis: a Rare Association2019 · 4 citations
  2. 2Systemic sclerosis2022 · 602 citations
  3. 3Systemic sclerosis and gastrointestinal involvement2020 · 8 citations
  4. 4AB0842 Anti-ku antibodies: Clinical and serological evaluation of 12 patients2012 · 1 citations
  5. 5Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists2017 · 39 citations